Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Cancer Research
|
March 15, 1994
Altered cytotoxicity of (2-chloroethyl)-3-sarcosinamide-1-nitrosourea in human glioma cell lines SK-MG-1 and SKI-1 correlates with differential transport kinetics
A J Noë, A Malapetsa, L C Panasci
Molecular Pharmacology
|
July 1, 1993
Transport of (2-chloroethyl)-3-sarcosinamide-1-nitrosourea in the human glioma cell line SK-MG-1 is mediated by an epinephrine-sensitive carrier system
A J Noë, A Malapetsa, L C Panasci
Cancer Research
|
September 1, 1995
Re: M. D. Dabholkar et al., Malignant and nonmalignant brain tissues differ in their messenger RNA expression patterns for ERCC1 and ERCC2. Cancer Res., 55: 1261-1266, 1995
L Panasci, A McQuillan, A Malapetsa, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1992
Lack of evidence for a high-affinity sarcosinamide carrier or a catecholamine carrier in Calu-1 lung-cancer cells, HT-29 colon-cancer cells, and DHF fibroblasts
A Malapetsa, J L Bramson, A J Noë, et al.
Biochemical Pharmacology
|
June 28, 1996
Characterization of the catecholamine extraneuronal uptake2 carrier in human glioma cell lines SK-MG-1 and SKI-1 in relation to (2-chloroethyl)-3-sarcosinamide-1-nitrosourea (SarCNU) selective cytotoxicity
A J Noë, D Marcantonio, J Barton, et al.
Analytical Biochemistry
|
January 1, 1997
Quantitation of ERCC-2 gene expression in human tumor cell lines by reverse transcription-polymerase chain reaction in comparison to northern blot analysis
Z P Chen, A Malapetsa, G Mohr, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 12, 2001
Chlorambucil drug resistance in chronic lymphocytic leukemia: the emerging role of DNA repair
L Panasci, J P Paiement, G Christodoulopoulos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 3, 1999
Chlorambucil induction of HsRad51 in B-cell chronic lymphocytic leukemia
G Christodoulopoulos, A Malapetsa, H Schipper, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society
|
April 20, 2001
Comparative analysis of human, bovine, and murine Oct-4 upstream promoter sequences
V Nordhoff, K Hübner, A Bauer, et al.
Cancer Research
|
June 1, 1996
Correlation of chloroethylnitrosourea resistance with ERCC-2 expression in human tumor cell lines as determined by quantitative competitive polymerase chain reaction
Z P Chen, A Malapetsa, D Marcantonio, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Cancer Research
|
March 15, 1994
Altered cytotoxicity of (2-chloroethyl)-3-sarcosinamide-1-nitrosourea in human glioma cell lines SK-MG-1 and SKI-1 correlates with differential transport kinetics
A J Noë, A Malapetsa, L C Panasci
Molecular Pharmacology
|
July 1, 1993
Transport of (2-chloroethyl)-3-sarcosinamide-1-nitrosourea in the human glioma cell line SK-MG-1 is mediated by an epinephrine-sensitive carrier system
A J Noë, A Malapetsa, L C Panasci
Cancer Research
|
September 1, 1995
Re: M. D. Dabholkar et al., Malignant and nonmalignant brain tissues differ in their messenger RNA expression patterns for ERCC1 and ERCC2. Cancer Res., 55: 1261-1266, 1995
L Panasci, A McQuillan, A Malapetsa, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1992
Lack of evidence for a high-affinity sarcosinamide carrier or a catecholamine carrier in Calu-1 lung-cancer cells, HT-29 colon-cancer cells, and DHF fibroblasts
A Malapetsa, J L Bramson, A J Noë, et al.
Biochemical Pharmacology
|
June 28, 1996
Characterization of the catecholamine extraneuronal uptake2 carrier in human glioma cell lines SK-MG-1 and SKI-1 in relation to (2-chloroethyl)-3-sarcosinamide-1-nitrosourea (SarCNU) selective cytotoxicity
A J Noë, D Marcantonio, J Barton, et al.
Analytical Biochemistry
|
January 1, 1997
Quantitation of ERCC-2 gene expression in human tumor cell lines by reverse transcription-polymerase chain reaction in comparison to northern blot analysis
Z P Chen, A Malapetsa, G Mohr, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 12, 2001
Chlorambucil drug resistance in chronic lymphocytic leukemia: the emerging role of DNA repair
L Panasci, J P Paiement, G Christodoulopoulos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 3, 1999
Chlorambucil induction of HsRad51 in B-cell chronic lymphocytic leukemia
G Christodoulopoulos, A Malapetsa, H Schipper, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society
|
April 20, 2001
Comparative analysis of human, bovine, and murine Oct-4 upstream promoter sequences
V Nordhoff, K Hübner, A Bauer, et al.
Cancer Research
|
June 1, 1996
Correlation of chloroethylnitrosourea resistance with ERCC-2 expression in human tumor cell lines as determined by quantitative competitive polymerase chain reaction
Z P Chen, A Malapetsa, D Marcantonio, et al.
Page
of 2